Found 5 with Last Name = 'salamoun' and Initial = 'jm' TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals Inc.
Boehringer Ingelheim Pharmaceuticals Inc.
Affinity DataIC50: 18nMAssay Description:The in vitro biochemical evaluation of all compounds was carried out using recombinant human PTP4A3, overexpressed as a His6-tag fusion protein in E....More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
University of Pittsburgh
Curated by ChEMBL
University of Pittsburgh
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Negative allosteric modulator activity at SHP2 (unknown origin)More data for this Ligand-Target Pair
3D Structure (crystal)TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals Inc.
Boehringer Ingelheim Pharmaceuticals Inc.
Affinity DataIC50: 132nMAssay Description:The in vitro biochemical evaluation of all compounds was carried out using recombinant human PTP4A3, overexpressed as a His6-tag fusion protein in E....More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
University of Pittsburgh
Curated by ChEMBL
University of Pittsburgh
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Negative allosteric modulator activity at SHP2 (unknown origin)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 3(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals Inc.
Boehringer Ingelheim Pharmaceuticals Inc.
Affinity DataIC50: 2.50E+5nMAssay Description:The in vitro biochemical evaluation of all compounds was carried out using recombinant human PTP4A3, overexpressed as a His6-tag fusion protein in E....More data for this Ligand-Target Pair
